Associate Director, Strategic Pricing, International Market Access & Pricing

AbbVie•Mettawa, IL

About The Position

The Associate Director, Strategic Pricing, iMAP will be responsible for calculating and articulating the financial impact of complex INTL pricing topics across the Therapeutics business. This includes high-priority areas such as the Most Favored Nations and International Reference Pricing Impact. The role demands agility in responding to evolving market dynamics and healthcare policy changes. The global healthcare landscape is experiencing profound transformation due to regulatory shifts, not only from US entities such as CMS, but also from international governing bodies and government initiatives targeting pharmaceutical cost optimization across markets. As a result, pharmaceutical companies are revising their business practices and financial strategies to align with evolving international pricing policies and reimbursement structures. These changes carry widespread implications, impacting market access, pricing, and profitability on a global scale. In this context, this position is essential for clearly articulating the financial impact of complex international pricing issues to senior management and the C-Suite, enabling informed decision-making and strategic planning in a highly dynamic international environment. This position reports to the Head of International Pricing.

Requirements

Bachelor’s degree in accounting or finance & 10+ years of related work experience, ideally in pharmaceutical industry.
CPA/MBA preferred.
Forecasting and Market Access Finance experience required.
Ability to synthesize / incorporate new topics to existing and quickly achieve subject matter expertise.
Ability to lead without authority.
Experience in leading and motivating a team in a dynamic business environment preferred.
Experienced Independent thinker who can work cross-functionally, demonstrating appropriate level of leadership.
Requires high levels of competence, confidence, and credibility.
Ability to make decisions without full data set or with ambiguity and uncertainty.
Experience supporting GM/VP level in performing planning activities and monitoring financial business results and targets preferred.
Excellent communication skills (both oral and written ) and ability to consistently provide clear and concise written and verbal communication, excellent presentation skills.
Ability to manage workload to meet critical deadlines under challenging time constraints.

Responsibilities

Lead pricing analytics and presentations associated with the impact of global pricing reforms—including MFN-based policies—across the international therapeutics portfolio. This includes a diverse set of in market and pipeline products with varying reimbursement structures and market access challenges across multiple geographies.
Build and maintain pricing models to simulate the impact of International Reference Pricing (IRP) and Most Favored Nations (MFN) clauses on global revenue.
Lead MFN discussions with senior management on an ad hoc basis, as well as during key planning cycles
Optimize the timing and order of product launches across international markets to minimize "price erosion" caused by cross-border reference benchmarking.
Develop "What-If" scenario planning for entry into new therapeutic areas, forecasting long-term price ceilings based on International Price Referencing competitor benchmarks.
Ensure the accuracy of the global pricing database to prevent "cascading" pricing errors that could trigger involuntary price cuts in linked markets.
Pricing lead in strategic discussions around MFN mitigation / revenue maximization with International and Global Pricing Council
Partner with Legal, Government Affairs, Market Access, Finance and other functions in INTL to determine impact of changes in US & INTL rules and regulations
Support Strategic Pricing Directors on an ad hoc basis as MFN Pricing subject matter expert
Lead the assessment and quantification of financial impact resulting from evolving healthcare policies, including International Reference Pricing, US Legislative changes and including Prescription Drug Affordability Board requests.
Anticipate and analyze implications of healthcare policy shifts from governing bodies (e.g., CMS, G-BA, MHML, CADTH, HAS) and new government initiatives (including Executive Orders), on INTL pricing strategies and business practices.
Develop and implement strategic recommendations to optimize pricing/sales impact in response to dynamic policy environments.
Build and maintain strong partnerships with cross-functional teams, including Market Access, BESD, Brand teams, US Pricing and Brand teams, to ensure alignment and effective execution of pricing strategies.
Synthesize complex data and insights into clear, actionable reports for Business Evolution and Strategy Development CoE.
Present findings and strategic recommendations to senior management, including C-Suite members, supporting evidence-based decision-making and long-term business planning.
Drive continuous improvement by leveraging data analytics and scenario planning to inform both short-term and long-term strategy development including futureproof alternative solutions (data strategy & dynamic capabilities)
Monitor global trends and best practices in healthcare policy and pricing to proactively identify opportunities and risks for the organization.
Lead the adoption of new pricing analytics tools and methodologies across international by demonstrating the "value-add" to the business and markets.
Simplify high-complexity pricing analytics into "board-ready" visualizations that enable informed, rapid decision-making in a dynamic environment.
Building and maintaining strong relationships with internal stakeholders and organizational leaders, in International Market Access and Pricing, INTL Finance, Business Evolution & Strategy Development , US Finance / Pricing and US Market Access.
Act as a consultative resource for Pricing leads across different business units, fostering a culture of rigorous, policy-aligned pricing thinking.